EI
Eikon Therapeutics, Inc. Common Stock (EIKN)
NASDAQ·Healthcare·Biotechnology
$9.31
-1.85%
Mkt Cap $44.00M
Analyst Ratings
Buy
0
Hold
0
Sell
2
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
-46.3%
Consensus $5.00 vs current $9.31